These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 17588602)

  • 21. Co-crystal structure and inhibition of factor Xa by PD0313052 identifies structurally stabilized active site residues of factor Xa and prothrombinase.
    Gould WR; Cladera E; Harris MS; Zhang E; Narasimhan L; Thorn JM; Leadley RJ
    Biochemistry; 2005 Jul; 44(26):9280-9. PubMed ID: 15981994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor Xa.
    Peraramelli S; Suylen DP; Rosing J; Hackeng TM
    Thromb Haemost; 2012 Aug; 108(2):266-76. PubMed ID: 22627666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa.
    Burgering MJ; Orbons LP; van der Doelen A; Mulders J; Theunissen HJ; Grootenhuis PD; Bode W; Huber R; Stubbs MT
    J Mol Biol; 1997 Jun; 269(3):395-407. PubMed ID: 9199408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative structural studies of two natural isoforms of ammodytoxin, phospholipases A2 from Vipera ammodytes ammodytes which differ in neurotoxicity and anticoagulant activity.
    Saul FA; Prijatelj-Znidarsic P; Vulliez-le Normand B; Villette B; Raynal B; Pungercar J; Krizaj I; Faure G
    J Struct Biol; 2010 Mar; 169(3):360-9. PubMed ID: 19857576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a homozygous Gly11Val mutation in the Gla domain of coagulation factor X.
    Chafa O; Tagzirt M; Tapon-Bretaudière J; Reghis A; Fischer AM; LeBonniec BF
    Thromb Res; 2009 May; 124(1):144-8. PubMed ID: 19135706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla).
    Kemball-Cook G; Johnson DJ; Tuddenham EG; Harlos K
    J Struct Biol; 1999 Oct; 127(3):213-23. PubMed ID: 10544046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new factor Xa inhibitor (lefaxin) from the Haementeria depressa leech.
    Faria F; Kelen EM; Sampaio CA; Bon C; Duval N; Chudzinski-Tavassi AM
    Thromb Haemost; 1999 Nov; 82(5):1469-73. PubMed ID: 10595640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Converting blood coagulation factor IXa into factor Xa: dramatic increase in amidolytic activity identifies important active site determinants.
    Hopfner KP; Brandstetter H; Karcher A; Kopetzki E; Huber R; Engh RA; Bode W
    EMBO J; 1997 Nov; 16(22):6626-35. PubMed ID: 9362477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rational design, synthesis, and structure-activity relationships of novel factor Xa inhibitors: (2-substituted-4-amidinophenyl)pyruvic and -propionic acids.
    Sagi K; Nakagawa T; Yamanashi M; Makino S; Takahashi M; Takayanagi M; Takenaka K; Suzuki N; Oono S; Kataoka N; Ishikawa K; Shima S; Fukuda Y; Kayahara T; Takehana S; Shima Y; Tashiro K; Yamamoto H; Yoshimoto R; Iwata S; Tsuji T; Sakurai K; Shoji M
    J Med Chem; 2003 May; 46(10):1845-57. PubMed ID: 12723948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Approaches to selective peptidic inhibitors of factor Xa.
    Bromfield KM; Quinsey NS; Duggan PJ; Pike RN
    Chem Biol Drug Des; 2006 Jul; 68(1):11-9. PubMed ID: 16923021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure and dynamics of zymogen human blood coagulation factor X.
    Venkateswarlu D; Perera L; Darden T; Pedersen LG
    Biophys J; 2002 Mar; 82(3):1190-206. PubMed ID: 11867437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor.
    Carlsson K; Freskgård PO; Persson E; Carlsson U; Svensson M
    Eur J Biochem; 2003 Jun; 270(12):2576-82. PubMed ID: 12787023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of an anticoagulant peptide that inhibits both fXIa and fVIIa/tissue factor from the blood-feeding nematode Ancylostoma caninum.
    Li D; He Q; Kang T; Yin H; Jin X; Li H; Gan W; Yang C; Hu J; Wu Y; Peng L
    Biochem Biophys Res Commun; 2010 Feb; 392(2):155-9. PubMed ID: 20059979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unexpected binding mode of tick anticoagulant peptide complexed to bovine factor Xa.
    Wei A; Alexander RS; Duke J; Ross H; Rosenfeld SA; Chang CH
    J Mol Biol; 1998; 283(1):147-54. PubMed ID: 9761680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular structures of human factor Xa complexed with ketopiperazine inhibitors: preference for a neutral group in the S1 pocket.
    Maignan S; Guilloteau JP; Choi-Sledeski YM; Becker MR; Ewing WR; Pauls HW; Spada AP; Mikol V
    J Med Chem; 2003 Feb; 46(5):685-90. PubMed ID: 12593649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tetrahydro-isoquinoline-based factor Xa inhibitors.
    Kucznierz R; Grams F; Leinert H; Marzenell K; Engh RA; von der Saal W
    J Med Chem; 1998 Dec; 41(25):4983-94. PubMed ID: 9836616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex.
    Majumder R; Quinn-Allen MA; Kane WH; Lentz BR
    Biochemistry; 2005 Jan; 44(2):711-8. PubMed ID: 15641797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SAR and X-ray structures of enantiopure 1,2-cis-(1R,2S)-cyclopentyldiamine and cyclohexyldiamine derivatives as inhibitors of coagulation Factor Xa.
    Qiao JX; Chang CH; Cheney DL; Morin PE; Wang GZ; King SR; Wang TC; Rendina AR; Luettgen JM; Knabb RM; Wexler RR; Lam PY
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4419-27. PubMed ID: 17588746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutagenesis studies toward understanding the mechanism of differential reactivity of factor Xa with the native and heparin-activated antithrombin.
    Rezaie AR; Yang L; Manithody C
    Biochemistry; 2004 Mar; 43(10):2898-905. PubMed ID: 15005625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloning and characterisation of an aspartyl protease inhibitor (API-1) from Ancylostoma hookworms.
    Delaney A; Williamson A; Brand A; Ashcom J; Varghese G; Goud GN; Hawdon JM
    Int J Parasitol; 2005 Mar; 35(3):303-13. PubMed ID: 15722082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.